GNC-039

GNC-039 · Sichuan Baili Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GNC-039, covering 2025-09-29 to 2025-09-29. Get the full timeline:

Most recent: Clinical Trial Update: A Study of GNC-039, a Tetra-specific Antibody, in Participants With Relapsed/Refractory or Metastatic Solid Tumors [Phase 1]

See pricing